Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$361,888,896
+$4,134,168 QoQ
Shares Held
2,816,256
-5.3% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#84
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $3,027,251,343 across 9 Drug Manufacturers - General names. MRK ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
640,845 | $768,648,782 | |
| 2 | JNJ |
Johnson & Johnson
|
2,438,843 | $619,392,956 | |
| 3 | ABBV |
AbbVie Inc.
|
1,761,265 | $443,204,724 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
2,816,256 | $361,888,896 | |
| 5 | AZN |
Astrazeneca PLC
|
1,526,363 | $289,428,952 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,648,030 | $208,212,110 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,765,830 | $159,367,124 | |
| 8 | PFE |
Pfizer Inc
|
6,258,004 | $150,692,736 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $361,888,896 | 2,816,256 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $357,754,728 | 2,974,102 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $312,661,461 | 2,970,373 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $309,975,898 | 3,693,267 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $287,579,808 | 3,632,893 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $280,166,900 | 3,121,289 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $308,518,118 | 3,101,308 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $279,052,918 | 2,457,317 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $294,706,642 | 2,380,506 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $328,284,342 | 2,487,945 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $273,720,765 | 2,510,739 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $287,873,215 | 2,796,243 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $325,164,633 | 2,817,962 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $282,100,743 | 2,651,572 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $291,976,241 | 2,631,602 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $243,356,000 | 2,825,778 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $264,967,279 | 2,906,299 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $241,413,908 | 2,942,278 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $223,048,072 | 2,910,335 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $222,095,686 | 2,956,939 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $234,858,710 | 3,019,914 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $260,608,743 | 3,380,576 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $287,917,136 | 3,519,771 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $272,443,095 | 3,284,424 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $259,309,177 | 3,353,279 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $257,136,987 | 3,342,047 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||